Related Experiment Video
Updated: Apr 28, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
LQT1 patients have augmented response of repolarization dispersion following atropine induced heart rate increase
Pia Dahlberg1,2, Karl-Jonas Axelsson1,2, Steen M Jensen3
1Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Abstract:
The long QT syndrome type 1 (LQT1) is caused by loss-of-function mutations affecting the potassium channel current IKs important for repolarization adaptation at heart rate (HR) increase. We therefore compared changes in three global VR dispersion parameters following a rapid, atropine-induced HR increase in LQT1 patients versus healthy controls applying Frank vectorcardiography. The adaptation patterns, magnitudes, and changing rates of T amplitude, T area, and the ventricular gradient were assessed during 5 min following injection. Twenty-one LQT1 patients and 31 controls were enrolled. HR increased similarly within ~23 s. The majority had a tri-phasic VR dispersion adaptation pattern: a rapid decrease to a minimum, a slower return to a slightly higher level, and a very slow almost horizontal decrease. In the LQT1 group, all three dispersion parameters had a longer lasting rapid phase and larger overshoot reaction, although statistically significant only for T amplitude. In conclusion, LQT1 was associated with an augmented adaptation of global dispersion parameters to a rapid HR increase versus healthy controls. Further studies are needed to determine how these observations relate to arrhythmogenesis and if the atropine test of QT interval and dispersion adaptation can be used in risk assessment on the individual level.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...